pixel50.gif l Detection l References l


pixel50.gifpixel5.gif


  Diagram 1.1, Prostate Cancer

 

  Diagram 1.2, Prostate Capsule Penetration

 

Power Doppler Imaging uses blood flow ultrasound technology and has been shown to accurately differentiate between cancer and benign prostatic hypertrophy (1) The sensitivity for malignancy diagnosis varies between 86% and 90% (2,3) Malignant vessels have multiple vascular pedicles and irregular sizes and distributions (4,5) Power Doppler Imaging is more sensitive than traditional Color Doppler Imaging (6,7)  (Fig. 1.1) The areas to which cancer spreads may also be evaluated (8) Areas of increased flow are 4.7 times more likely to contain cancer (9) Patients with low grade cancers may be observed and followed by this technique (10,11,12) Physicians may choose to use this exam to follow up previously biopsied, operated or post radiation patients with elevated PSA levels.  Decreased blood flow correlates well with tumor response to non operative treatments (13) Calculi and abscesses causing chronic/recurrent prostatitis may be studied and aspirated (14) Postbiopsy artifacts limit early usage of MRI scanning (15) and spectroscopic MRI (16) Tumor hypervascularity correlates with metastatic potential (17,18,19,20,21) The prostatic capsular region may be reliably imaged (22,23) and the spread of cancer through the capsule documented (Fig. 1.2)

 

 






1.  Okihara K:

Tohuku J Exp Med 182:277, 1997

2.  Cho JY:

J Ultrasound Med 17:283, 1998


3.
  Sakaryu M:

Br J Urol 82:386, 1998

4.
  Campani R:

AIUM Annual Conference 1995

 

5.  Strum S:

Proc Inst Prostate Cancer Research  1998

 

6.  Solbiati G:

Superficial Structures  Churchill  1996

 

7 American College of Radiology  Standards Guide 2001

 

8.  Bard R:

Norris Cancer Center   Los Angeles  1999

 

9:  Halpern E:

American Journal Radiology  174:623, 2000

 

10.  Okihara K:

 Br J Urol 84:333, 2000

 

11.  Cosgrove D:

Diagnostic Imaging  22:69, 2000

 

12.  Cornud F:

 American Journal Radiology 174:1161, 2000

 

13.  Bard R:

Dept Urology Columbia Presbyterian Med   2001

 

14.  Johns Hopkins Medical Letter 3:3, 2001

 

15.  Cornud F.

French J Radiol 49:1187, 2001

 

16.  Bard R:

Service D'urologie  Hosp Necker  Paris 2001

 

17.  Lassau N:

American Journal Radiology 178: 1547, 2002

 

18.  Lee F:

Prostate Center Symposium  Commerce, MI 2002

 

19.  Bahn D:

Proc Inst Prostate Cancer Research 5:1, 2002    

 

20.  Brown D:

Radiology Today  4:16, 2003

 

21.  Bard R:

Dept of Radiology, Hosp  Necker  Paris 2003

 

22.  Sauvain JL:

Eur Urol 44:21, 2003

 

23.  Bard R:

American Roengtgen Ray Society  Miami 2004

 

 




Robert L. Bard, MD
121 E. 60th Street
New York, New York 10022
phone:(212) 355-7017, fax:(212) 752-6192